Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not receive 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Patient received 1st dose in 2020). On an unknown date, the patient did not receive the 2nd dose of Shingrix, the patient experienced incomplete course of vaccination (Verbatim: did not receive 2nd dose yet). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 09-JUL-2025 A patient received the first dose of Shingrix in 2020 and has not yet received the second dose, which led to incomplete course of vaccination. The reporter did not wish to provide the date of birth of the patient.